2015 American Transplant Congress
Donor Selection and Prophylactic IVIg for Induction Immunosuppression Improves Outcomes for HIV+ Kidney Transplant Recipients (HIV+ Tx)
HIV+ Tx recipients are noted to have higher rates of allorecognition through cellular and humoral mediated pathways. Since 2010, our program instituted IVIg use as…2015 American Transplant Congress
Combined Hepatitic/Cholangiopathic Lesion in HIV-HCV Co-Infected Liver Transplant Recipients Associated With Graft Loss
Background: Co-infection with HIV and viral hepatitis results in poorer outcomes following liver transplantation. In this population, complex immune status, extensive drug regimens, and comorbid…2015 American Transplant Congress
Estimated Prevalence of HIV in Kidney Transplant Candidates
Surgery, Johns Hopkins University, Baltimore, MD.
The passage of the HOPE Act in November 2013 mandated research into HIV+ to HIV+ organ transplantation. To date, the prevalence of HIV in the…2015 American Transplant Congress
Geographic Differences in HIV+ Kidney Transplant Waitlist Characteristics
Kidney transplant (KT) is now a viable option for select HIV+ end-stage renal disease (ESRD) patients. As OPTN does not collect HIV status at waitlisting,…2015 American Transplant Congress
Survival Benefit of Liver Transplant Among HIV+ Waitlist Candidates
Liver failure is the most common cause of non-AIDS related death among HIV+ patients, primarily due to high prevalence of co-infection with hepatitis C (HCV)…2015 American Transplant Congress
Development of a Risk Assessment Model for HIV Among Increased Risk Deceased Donors With Negative Nucleic Acid Testing
Centers for Disease Control and Prevention, Atlanta, GA.
Background: In 2013, guidelines for reducing the risk of HIV, hepatitis B and C disease transmission through organ transplants were released. These include criteria which…2015 American Transplant Congress
Racial Differences in Transplant and Waitlist Mortality Rates Among HIV+ Kidney Transplant Candidates
Kidney transplant (KT) is now a viable option for select HIV+ end-stage renal disease patients. As OPTN does not collect HIV status at waitlisting, no…2015 American Transplant Congress
Screening Recipients of Increased Risk Donor Organs: A Multicenter Study
Purpose: Policy mandates post-transplant (tx) evaluation of recipients of increased risk donor organs (ROIRDO). PHS guidelines recommend that screening include HIV & hepatitis C virus…2015 American Transplant Congress
Changing Demographics of HIV+ Liver Transplant Candidates
Liver transplant (LT) is considered a reasonable therapeutic option for certain HIV+ patients with end-stage liver disease (ESLD). As OPTN does not collect HIV status…2015 American Transplant Congress
Defining the Epidemiologic Landscape of HIV-Infected Deceased Donors in the United States
Surgery, Johns Hopkins University, Baltimore, MD.
The HIV Organ Policy Equity Act mandates research on the use of HIV-infected (HIV+) deceased donors (HIVDD) for transplantation in HIV+ recipients. The only data…
American Transplant Congress abstracts